These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17909051)

  • 21. A dialog between glioma and microglia that promotes tumor invasiveness through the CCL2/CCR2/interleukin-6 axis.
    Zhang J; Sarkar S; Cua R; Zhou Y; Hader W; Yong VW
    Carcinogenesis; 2012 Feb; 33(2):312-9. PubMed ID: 22159219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre-clinical model.
    Melnyk O; Zimmerman M; Kim KJ; Shuman M
    J Urol; 1999 Mar; 161(3):960-3. PubMed ID: 10022734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells.
    Chiu HY; Sun KH; Chen SY; Wang HH; Lee MY; Tsou YC; Jwo SC; Sun GH; Tang SJ
    Cytokine; 2012 Aug; 59(2):423-32. PubMed ID: 22617682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice.
    Zhang F; Lu W; Dong Z
    Clin Cancer Res; 2002 Sep; 8(9):2942-51. PubMed ID: 12231540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A high-fat diet enhances proliferation of prostate cancer cells and activates MCP-1/CCR2 signaling.
    Huang M; Narita S; Numakura K; Tsuruta H; Saito M; Inoue T; Horikawa Y; Tsuchiya N; Habuchi T
    Prostate; 2012 Dec; 72(16):1779-88. PubMed ID: 22514016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy.
    Zhu X; Fujita M; Snyder LA; Okada H
    J Neurooncol; 2011 Aug; 104(1):83-92. PubMed ID: 21116835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting epitopes in prostate-specific membrane antigen for antibody therapy of prostate cancer.
    Kinoshita Y; Kuratsukuri K; Newman N; Rovito PM; Kaumaya PT; Wang CY; Haas GP
    Prostate Cancer Prostatic Dis; 2005; 8(4):359-63. PubMed ID: 16172607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
    Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
    Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo.
    Henry JY; Lu L; Adams M; Meyer B; Bartlett JB; Dalgleish AG; Galustian C
    Prostate; 2012 Jun; 72(8):856-67. PubMed ID: 21968939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
    Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
    FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of periostin in cancer progression and metastasis: inhibition of breast cancer progression and metastasis by anti-periostin antibody in a murine model.
    Kyutoku M; Taniyama Y; Katsuragi N; Shimizu H; Kunugiza Y; Iekushi K; Koibuchi N; Sanada F; Oshita Y; Morishita R
    Int J Mol Med; 2011 Aug; 28(2):181-6. PubMed ID: 21617848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The disintegrin contortrostatin in combination with docetaxel is a potent inhibitor of prostate cancer in vitro and in vivo.
    Lin E; Wang Q; Swenson S; Jadvar H; Groshen S; Ye W; Markland FS; Pinski J
    Prostate; 2010 Sep; 70(12):1359-70. PubMed ID: 20623636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases.
    Craig MJ; Loberg RD
    Cancer Metastasis Rev; 2006 Dec; 25(4):611-9. PubMed ID: 17160712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice.
    Wallner L; Dai J; Escara-Wilke J; Zhang J; Yao Z; Lu Y; Trikha M; Nemeth JA; Zaki MH; Keller ET
    Cancer Res; 2006 Mar; 66(6):3087-95. PubMed ID: 16540658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer.
    Miwa S; Mizokami A; Keller ET; Taichman R; Zhang J; Namiki M
    Cancer Res; 2005 Oct; 65(19):8818-25. PubMed ID: 16204052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
    Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
    Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice.
    Maus U; von Grote K; Kuziel WA; Mack M; Miller EJ; Cihak J; Stangassinger M; Maus R; Schlöndorff D; Seeger W; Lohmeyer J
    Am J Respir Crit Care Med; 2002 Aug; 166(3):268-73. PubMed ID: 12153956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Docetaxel followed by castration improves outcomes in LNCaP prostate cancer-bearing severe combined immunodeficient mice.
    Tang Y; Khan MA; Goloubeva O; Lee DI; Jelovac D; Brodie AM; Hussain A
    Clin Cancer Res; 2006 Jan; 12(1):169-74. PubMed ID: 16397039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting of CCL2-CCR2-Glycosaminoglycan Axis Using a CCL2 Decoy Protein Attenuates Metastasis through Inhibition of Tumor Cell Seeding.
    Roblek M; Strutzmann E; Zankl C; Adage T; Heikenwalder M; Atlic A; Weis R; Kungl A; Borsig L
    Neoplasia; 2016 Jan; 18(1):49-59. PubMed ID: 26806351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.